These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8725389)

  • 21. Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions.
    Crumb WJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):261-4. PubMed ID: 10604956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system.
    Ali Z; Ismail M; Khan F; Sajid H
    Expert Opin Drug Saf; 2021 Jan; 20(1):101-107. PubMed ID: 33141610
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular safety of second-generation antihistamines.
    Barbey JT; Anderson M; Ciprandi G; Frew AJ; Morad M; Priori SG; Ongini E; Affrime MB
    Am J Rhinol; 1999; 13(3):235-43. PubMed ID: 10392245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands.
    Herings RM; Stricker BH; Leufkens HG; Bakker A; Sturmans F; Urquhart J
    Pharm World Sci; 1993 Oct; 15(5):212-8. PubMed ID: 8257958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-sedating antihistamines and cardiac arrhythmia.
    Rankin AC
    Lancet; 1997 Oct; 350(9085):1115-6. PubMed ID: 9343494
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
    Hey JA; del Prado M; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QT prolongation and safety in the Indian population.
    Dabhi J; Mehta A
    Curr Drug Saf; 2007 Sep; 2(3):200-3. PubMed ID: 18690968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
    Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
    Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihistamines.
    Armstrong SC; Cozza KL
    Psychosomatics; 2003; 44(5):430-4. PubMed ID: 12954920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torsades de pointes occurring in association with terfenadine use.
    Monahan BP; Ferguson CL; Killeavy ES; Lloyd BK; Troy J; Cantilena LR
    JAMA; 1990 Dec; 264(21):2788-90. PubMed ID: 1977935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
    Kaliner MA
    Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsade de pointes induced by terfenadine in a patient with long QT syndrome.
    Koh KK; Rim MS; Yoon J; Kim SS
    J Electrocardiol; 1994 Oct; 27(4):343-6. PubMed ID: 7815014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.
    Husain Z; Hussain K; Nair R; Steinman R
    Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terfenadine should be withdrawn from clinical use.
    Khilnani G
    J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
    [No Abstract]   [Full Text] [Related]  

  • 35. [Extension of QT interval as a consequence of risk factor accumulation--case study].
    Sisáková M; Toman O; Floriánová A; Kadlecová J; Chroust K; Papousek I; Spinar J
    Vnitr Lek; 2006 Mar; 52(3):271-3. PubMed ID: 16722159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of potassium channels by nonsedating antihistamines.
    Berul CI; Morad M
    Circulation; 1995 Apr; 91(8):2220-5. PubMed ID: 7697852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torsades de pointes induced by nonantiarrhythmic drugs.
    Tran HT
    Conn Med; 1994 May; 58(5):291-5. PubMed ID: 7915666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac safety of second-generation H
    Cataldi M; Maurer M; Taglialatela M; Church MK
    Clin Exp Allergy; 2019 Dec; 49(12):1615-1623. PubMed ID: 31519068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.